S. Seifert

发表

Novel tumortropic ester derivatives of 99mTc(V) mesodimercapto succinic acid with low affinity for bone tissue

H. Spies, B. Johannsen, R. Syhre, 2003, Nuclear medicine communications.

Synthesis, biological and autoradiographic evaluation of a novel Tc-99m radioligand derived from WAY 100635 with high affinity for the 5-HT(1A) receptor and the alpha1-adrenergic receptor.

P. Brust, C. Halldin, K. Varnäs, 2002, Nuclear medicine and biology.

Properties of lubrol-solubilized acetylcholine receptor from Torpedo electroplax.

R. O'brien, A. Eldefrawi, M. Eldefrawi, 1972, Archives of biochemistry and biophysics.

Chemical and biological characterization of technetium(I) and Rhenium(I) tricarbonyl complexes with dithioether ligands serving as linkers for coupling the Tc(CO)(3) and Re(CO)(3) moieties to biologically active molecules.

H. Spies, B. Johannsen, P. Schubiger, 2000, Bioconjugate chemistry.

Synthesis and autoradiographic evaluation of a novel high-affinity Tc-99m ligand for the 5-HT2A receptor.

M. Scheunemann, P. Brust, H. Spies, 1999, Nuclear Medicine and Biology.

No carrier added preparations of ‘3 + 1’ mixed-ligand 99mTc complexes

M. Scheunemann, H. Spies, B. Johannsen, 1998 .

TROTEC-1: a new high-affinity ligand for labeling of the dopamine transporter.

P. Brust, H. Spies, B. Johannsen, 1998, Journal of medicinal chemistry.

Dramatic effect of the tridentate ligand on the stability of 99mTC "3 + 1" oxo complexes bearing arylpiperazine derivatives.

J. Correia, R. Bergmann, H. Spies, 2005, Bioconjugate chemistry.

Stability versus reactivity of ”3+1” mixed-ligand technetium-99m complexes in vitro and in vivo

H. Spies, B. Johannsen, R. Syhre, 1998, European Journal of Nuclear Medicine.

Synthesis and biological evaluation of silylated mixed-ligand 99mTc complexes with the [PNS/S] donor atom set.

H. Spies, T. Kniess, L. Gano, 2004, Nuclear medicine and biology.

Preparation and characterization of novel mixed-ligand oxorhenium(V) and oxotechnetium(V) complexes bearing up to four ester groups

H. Spies, B. Johannsen, A. Hoepping, 1997 .

Radiochemical purity of 99mTc-HM-PAO: critical parameters during kit preparation.

B. Johannsen, S. Seifert, O. Muth, 1995, Nuclear medicine and biology.

Affinity of myasthenia drugs to acetylcholinesterase and acetylcholine receptor.

M. Eldefrawi, S. Seifert, 1974, Biochemical medicine.

Assessment of the in vitro and in vivo properties of a (99m)Tc-labeled inhibitor of the multidrug resistant gene product P-glycoprotein.

M. Scheunemann, P. Brust, R. Bergmann, 2000, Nuclear medicine and biology.

Novel enantiopure ferrugininoids active as nicotinic agents: synthesis and radioligand binding studies.

D. Gündisch, M. C. Tilotta, G. Seitz, 2004, Die Pharmazie.

Improved synthesis and in vitro evaluation of quinuclidin-2-ene based ligands for the nicotinic acetylcholine receptor.

D. Gündisch, M. C. Tilotta, G. Seitz, 2003, Pharmazie.

Synthesis and biological evaluation of technetium(III) mixed-ligand complexes with high affinity for the cerebral 5-HT(1A) receptor and the alpha1-adrenergic receptor.

C. Halldin, K. Varnäs, H. Hall, 2002, Nuclear medicine and biology.

Reactivity of 99mTc(V) ''3+1''mixed-ligand complexes towards glutathione

M. Scheunemann, P. Brust, B. Johannsen, 2001 .

Cyclopentadienyl tricarbonyl complexes of 99mTc for the in vivo imaging of the serotonin 5-HT1A receptor in the brain

R. Bergmann, H. Pietzsch, S. Seifert, 2004 .

Synthesis and characterization of novel trigonal bipyramidal technetium(III) mixed-ligand complexes with SES/S/P coordination (E = O, N(CH3), S).

H. Spies, F. Tisato, H. Pietzsch, 2001, Inorganic chemistry.